Abstract
The Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE) is a National Health and Medical Research Council (NHMRC)-funded Centre of Research Excellence (CRE). The Centre is a nationally-distributed, multidisciplinary team of experts that will conduct high-impact research to strengthen Australia's emergency response to infectious diseases.
Announced in June 2016, this CRE is unique on the basis of the total funding and the scope of work. In the first year, the remit is to complete a targeted consultation of stakeholders across Australia to determine what research activities and protocols, training opportunities and pathways, collaborative partnerships and cross-sectoral linkages should be prioritised to ensure Australia is equipped for a more coordinated, effective and evidence-based response to infectious disease outbreaks.
The consultation's stakeholder engagement process includes interviews and workshops with government and non-government stakeholders, ranging from government policy makers, clinicians, researchers and infection prevention specialists to consumers.
Proposed research priorities will be discussed, with analysis and consideration of stakeholder views then incorporated into a final consultation report.
This report, to be tabled in June 2017, will be evaluated by the NHMRC and the Australian Health Protection Principal Committee (AHPPC) and approval will be required prior to funding allocation.
Announced in June 2016, this CRE is unique on the basis of the total funding and the scope of work. In the first year, the remit is to complete a targeted consultation of stakeholders across Australia to determine what research activities and protocols, training opportunities and pathways, collaborative partnerships and cross-sectoral linkages should be prioritised to ensure Australia is equipped for a more coordinated, effective and evidence-based response to infectious disease outbreaks.
The consultation's stakeholder engagement process includes interviews and workshops with government and non-government stakeholders, ranging from government policy makers, clinicians, researchers and infection prevention specialists to consumers.
Proposed research priorities will be discussed, with analysis and consideration of stakeholder views then incorporated into a final consultation report.
This report, to be tabled in June 2017, will be evaluated by the NHMRC and the Australian Health Protection Principal Committee (AHPPC) and approval will be required prior to funding allocation.
| Original language | English |
|---|---|
| Pages (from-to) | E2-E3 |
| Number of pages | 3 |
| Journal | Communicable Diseases Intelligence Quarterly Report |
| Volume | 41 |
| Issue number | 1 |
| Publication status | Published - 31 Mar 2017 |